Apellis Pharmaceuticals Inc (APLS)
Apellis and Sobi Announce EMPAVELI®(pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
Apellis and Sobi Announce EMPAVELI®(pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
Senti Bio to Participate in a Virtual Fireside Chat Hosted by Chardan Capital Markets, LLC
Jaguar Health to Conduct Fireside Chat June 10 Regarding Companys Efforts to Further its Orphan Disease Development Programs as Part of LythamPartners’ Spring 2025 Spotlight Series
Greg Kidd to Acquire Controlling Interest in Know Labs and Introduce Bitcoin Treasury Strategy
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
Alvotech tekur þátt í árlegri heilbrigðisráðstefnu Goldman Sachs fjárfestingabankans í Miami
Alvotech Participates in the Goldman Sachs Global Healthcare Conference in Miami